Why Zimmer Biomet Holdings, Inc.’s (ZBH) Stock Is Up 12.52%
As of Wednesday, November 04, Zimmer Biomet Holdings, Inc.’s ZBH share price has surged by 12.52%, which has investors questioning if this is right time to sell.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Rosalio Madrigal
Jenna Brashear
Tudor Pop
Michael Rose
| Share Statistics | ZBH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $19,320.9 | $372.7 | 86% |
|
| Shares Out (Mil) | 191.4 | 41.4 | 74% |
|
| Institutional Ownership | 99.8% | 84.0% | 94% |
|
| Float (Mil) | 188.6 | 35.6 | 72% |
|
| Beta | 0.47 | 0.87 | 25% |
|
| Avg Daily Volume (000s) | 2,879 | 323 | 85% |
|
| Price Change (52-week) |
13.6% | 57.5% | 65% |
|
| Growth | ZBH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 6.1% | 11.8% | 42% |
|
| Net Income (5yr) | 47.9% | (5.7%) | 93% |
|
| EPS (5yr) | 48.8% | 10.6% | 93 |
|
| Dividends (5yr) | 0.0% | 0.0% | 78% |
|
| Cash Flow (5yr) | (17.5%) | (15.8%) | 40% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 24 | 27 | 27 | |
| Current EPS | $2.494 | $8.554 | $8.974 | |
| Month Ago EPS | $2.493 | $8.534 | $9.053 | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 1 | 1 | 0 | |
| Three Months Ago EPS | $2.493 | $8.534 | $9.067 | |
| Year/Year Chg | 149.4% | 141.0% | 170.2% | |
| Financials | ZBH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $8,570 | $125 | 82% |
|
| Net Income (TTM) (Mil) | $767 | ($9) | 83% |
|
| EPS (TTM) | $3.961 | ($0.300) | 82% |
|
| Operating Cash Flow (TTM) (Mil) | $1,885 | ($1) | 87% |
|
| Net Cash Flow (TTM) (Mil) | ($893) | $2 | 3% |
|
| Long-Term Debt (Q1) (Mil) | $6,370 | $21 | 88% |
|
| Enterprise Value (Q1) (Mil) | $26,773 | $381 | 87% |
|
| Valuation | ZBH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.53 | 2.58 | 46% |
|
| P/E | 25.8 | 25.8 | 67% |
|
| Dividend Yield | 0.9% | 0.0% | 65% |
|
| PEG (5yr hist) | 0.2 | 1.3 | 8% |
|
| Ratios | ZBH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 69.3% | 59.5% | 80% |
|
| Net Margin | 9.0% | (4.5%) | 59% |
|
| ROA | 3.3% | (10.1%) | 62% |
|
| ROE | 6.0% | (8.3%) | 45% |
|
| Liabilities to Assets | 45.9% | 45.8% | 37% |
|
| F-Score | 6 | 4 | 67% |
|
Zimmer Biomet Holdings, Inc. did not pass any screens on 11/17/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors